The global EMEA Blood Glucose Monitoring market garnered revenue around USD 561 million in 2019 and projected to reach USD XX Billion in 2027, with at a compound annual growth rate of 6.3% throughout the estimate period from 2020 to 2027.
One of the main objectives of diabetes treatment is to keep blood glucose level within a specified target range. Blood glucose monitoring is a process, which helps to identify the blood glucose level and notify if glucose level of blood is exceeding the limit. Thus, it helps to understand the food intake, exercise, insulin, and blood glucose level. The blood glucose monitoring devices provide useful information to manage diabetes. It helps to track the progress of treatment goal as well as monitor the effect of diabetes meditation on blood sugar level and understand the effect of illness and stress on the blood sugar level.
This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.
The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the EMEA Blood Glucose Monitoring market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the EMEA Blood Glucose Monitoring market growth.
The global EMEA Blood Glucose Monitoring market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.
Major manufacturers analysed under this study comprises:
Some of the key players in this market are Abbott Laboratories (US), Arkay Inc. (Japan), Bayer Healthcare AG, (Germany), F.Hoffmann-La Roche (Switzerland), LifeScan, Johnson & Johnson (U.S.), Medtronic plc., Nipro Diagnostics Inc., and Terumo Medical Corporation.
This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:
On the basis of the product type, it is segmented into invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), flash glucose monitoring devices, and others.
On the basis of the application, it is segmented into type 1 diabetes, type 2 diabetes, and others.
On the basis of the end user, it is segmented into diagnostic centers, hospitals, clinics, research centers, and home care diagnostics.
Regional Analysis and Forecast
Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:
North America
? U.S.
? Canada
Europe
? Germany
? U.K.
? Italy
? France
? Rest of EU
Asia Pacific
? China
? India
? Japan
? Southeast Asia
? Rest of APAC
Central & South America
? Brazil
? Argentina
? Rest of Central & South America
Middle East and Africa
? UAE
? Saudi Arabia
? Rest of MEA
Request Customization
Get a Sample
Get a Sample
Request Customization